why choose us

First received: May 22, 2024

Clinical Trial: Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Overweight and Obesity

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apitegromab in Overweight and Obese Adult Subjects

Brief Summary: A phase 2 study to evaluate the effects of apitegromab as an adjunctive therapy to GLP-1 receptor agonist therapy in subjects with overweight or obesity

Read more